Gastroenterology

It’s Digestive Disease Week(DDW) in Orlando’s Orange County Convention Center. At the event, PillCam capsule endoscopy pioneer Given Imaging Ltd, has … continue reading “PillCam Starting To Look Like A Diagnostic Option Say Studies”

In short Surgical adhesive and sealant company, Cohera Medical, Inc.® , has announced that it has received approval to begin … continue reading “European Clinical Trial Of New Bowel Sealant To Commence”

Israeli medtech outfit GI Dynamics, Inc. has launched its EndoBarrier® in its home market. The company has announced that The Sheba Medical Center (Tel Hashomer) at Ramat-Gan, Israel, is the first to offer the therapy, a non-surgical, non-pharmaceutical treatment for type 2 diabetes and/or obesity.

GI Dynamics, Inc. has announced that it has initiated its U.S. multicentre pivotal clinical trial of EndoBarrier®, the ENDO Trial, for the treatment of patients who have uncontrolled type 2 diabetes and are obese.

Capsule endoscopy company Given Imaging Ltd. has acquired from The SmartPill Corporation, a U.S. based-company, the assets related to the SmartPill® GI Monitoring System for $6 million including earn-outs based on revenue between now and 2016.

Given Imaging Ltd. developer of the Pillcam Colon 2 swallowable camera system for visualisation of the colorectal lining, has submitted compelling trial data to the Japanese authorities showing that 94% of polyps identified using standard colonoscopy were also spotted by its device.

Covidien says its newly FDA cleared device is the world’s only fully powered reusable surgical EndoStapling platform and claims it sets new standards in precision during surgery.

Ageing population, improved screening and new treatments will drive GI Endoscopy market in U.S.A

GI Dynamics, Inc. has announced that it has received conditional approval from the U.S. FDA to commence what it’s calling a pivotal clinical trial of the EndoBarrier® for the treatment of patients who have uncontrolled type 2 diabetes and are obese.

EndoStim B.V. has announced CE Mark approval of its LES Stimulation System for the treatment of gastro-esophageal reflux disease (GERD). The system uses low energy electrical pulses to strengthen a weak or dysfunctional lower esophageal sphincter muscle.

Are the summer doldrums a good time to bury bad news or an opportunity to get your story to the top of the editor’s “hmmm interesting” list? We ponder this and other matters in our weekly View From The Med.

Steris Corporation is to acquire United States Endoscopy Group, Inc. and in so doing significantly expand its presence in the gastrointestinal(GI) procedural market with a franchise of proprietary, single-use consumable medical devices.

Cook Medical has gained 510(k) clearance for its Evolution® Colonic Controlled-Release Stent. The new stent is used to palliate uncomfortable symptoms associated with colonic obstructions caused by malignant neoplasms and relieve large-bowel obstructions prior to colectomy procedures.

More clinical evidence, presented last week, supports GI Dynamics’ case that its EndoBarrier® gastrointestinal lining device represents an effective therapeutic option in overweight and mildly obese type II diabetic patients.

Covidien says its new Radial Reload allows surgeons to cut and securely staple colon tissue up to 2 cm deeper into the pelvis than the Ethicon Contour® Curved Cutter Stapler.

ConvaTec has followed up its May announcement of the acquisition of AbViser Medical, LLC with the news that its ostomy systems range is to expand with the acquisition of UK company Trio Healthcare International Ltd.